KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Novavax (NVAX) Net Income towards Common Stockholders: 2009-2024

Historic Net Income towards Common Stockholders for Novavax (NVAX) over the last 16 years, with Dec 2024 value amounting to -$187.5 million.

  • Novavax's Net Income towards Common Stockholders fell 66.84% to -$202.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $341.7 million, marking a year-over-year increase of 219.97%. This contributed to the annual value of -$187.5 million for FY2024, which is 65.60% up from last year.
  • According to the latest figures from FY2024, Novavax's Net Income towards Common Stockholders is -$187.5 million, which was up 65.60% from -$545.1 million recorded in FY2023.
  • In the past 5 years, Novavax's Net Income towards Common Stockholders ranged from a high of -$187.5 million in FY2024 and a low of -$1.7 billion during FY2021.
  • For the 3-year period, Novavax's Net Income towards Common Stockholders averaged around -$463.5 million, with its median value being -$545.1 million (2023).
  • Per our database at Business Quant, Novavax's Net Income towards Common Stockholders crashed by 316.91% in 2021 and then soared by 65.60% in 2024.
  • Over the past 5 years, Novavax's Net Income towards Common Stockholders (Yearly) stood at -$418.3 million in 2020, then crashed by 316.91% to -$1.7 billion in 2021, then surged by 62.27% to -$657.9 million in 2022, then climbed by 17.16% to -$545.1 million in 2023, then skyrocketed by 65.60% to -$187.5 million in 2024.